Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists. - Wikidata - wikimedia - TriplyDB

Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.

Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.

http://www.wikidata.org/entity/Q38397291

about

Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.Primordial Follicle Transplantation within Designer Biomaterial Grafts Produce Live Births in a Mouse Infertility Model Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Investigational and experimental GnRH analogs and associated neurotransmitters.Acute lymphoblastic leukemia in adolescents and young adults.Infertility - Prevention and Management.Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix.Endocrine prevention of chemotherapy-induced ovarian failure.Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.

P2860

Q33625789-FF0E8DD0-29D2-406C-B636-36FB35B89C97 Q36217531-DF657FC7-EB14-494F-BF0D-901C72B35552 Q36343842-7C66914E-BBFD-4741-886A-922D90CA5A54 Q37633480-83903740-DA32-46E3-BC2D-2FF6A90CE81D Q38682630-D687E6E7-349D-4B73-A6B6-806A3194759E Q38691029-B6F8A440-4A3C-4BD8-B4C4-282F3A3F2DD3 Q39192991-F81EFA89-8085-4890-931C-383EE9567A54 Q39228582-845B2100-6C1E-4249-ABE2-2B76C40B135B Q42253770-7B3C337B-AA56-4101-B259-4013ED0254C2 Q43958170-2695C4F2-6737-40E3-A249-D6EC9BF1D26F Q47656974-6C643EB4-CE94-4CF1-A863-7906C6515CD3 Q50947107-8B91785E-29F5-4C3F-816A-F71051886E46

P2860

Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.

http://www.wikidata.org/entity/Q38397291

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Preserving fertility when choo ...... in-releasing hormone agonists.

@en

type

label

Preserving fertility when choo ...... in-releasing hormone agonists.

@en

prefLabel

Preserving fertility when choo ...... in-releasing hormone agonists.

@en

P1433

Q38397291-A67CE044-FF20-42B0-A9C5-C414A273835F

P1476

Q38397291-B3AD9E4B-780D-4C29-B927-83715F6CA912

P2093

Q38397291-72F9F548-1722-423F-921A-709437916263

Q38397291-B6CA193F-B20D-4051-BB42-7F6F931507DA

P2860

Q38397291-01865E58-BD44-4DEE-9B4E-860B622FDCD2

Q38397291-05FD80AA-F908-48A3-BA84-BCF5275A3DC2

Q38397291-0A78B512-1214-4AFD-99B5-9248245F5E10

Q38397291-0CA84B1D-7CA9-46B8-88F1-080146A0DC40

Q38397291-0E6A5790-4B47-437D-B2F4-0B9EE0AC7C94

Q38397291-12B6E980-7CB2-456F-81FD-61A3ED23823D

Q38397291-1474C203-EDDD-4AB8-8AD5-7BC9B98B0687

Q38397291-17CB3274-EC44-41FC-B93A-754ED93B9DB3

Q38397291-197F17BB-AD44-4DA7-903E-8AF07A261C39

Q38397291-1B732F62-BA59-491D-B67E-79A7FF8B4A8E

P304

Q38397291-0B95C16D-96A9-473C-A812-2EEABC5086D6

P31

Q38397291-5D2B3AA7-8CF5-49F5-9CFB-93661F1CA448

P356

Q38397291-C061AA32-AD0F-4CFA-8365-1F2B4DC4D52E

P407

Q38397291-8AF7895C-CBDA-4608-AB4C-26C7ED1098DC

P433

Q38397291-4E60A799-7B77-417E-9168-7B8633B02622

P478

Q38397291-4015DAB5-25F4-47B8-8604-8AA68F6418D1

P577

Q38397291-98B90779-0737-478E-9D38-59BAF89A934B

P5875

Q38397291-F6E741F4-41DC-4F58-8F08-B74765FAD40F

P698

Q38397291-D98481DE-7B3E-4036-91F1-60F1A70B15C2

P921

Q38397291-3B7BF240-591B-4655-B28B-9FB1D60A21A7

P356

14656566.2015.1031654

P1433

Expert Opinion on Pharmacotherapy

P1476

Preserving fertility when choo ...... in-releasing hormone agonists.

@en

P2093

Ayelet Evron

http://www.w3.org/2001/XMLSchema#string

Zeev Blumenfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Cancer statistics, 2015

Occasional involvement of the ovary in Ewing sarcoma

Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.

GnRH-agonists in fertility preservation.

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study

P304

1009-1020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1031654

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274317876

http://www.w3.org/2001/XMLSchema#string

P698

25826240

http://www.w3.org/2001/XMLSchema#string

P921